Phase i study of recombinant cea vaccinia virus vaccine with post vaccination cea peptide challenge

Human Gene Therapy

Volumn 7, Issue 11, 1996, Pages 1381-1394

  Cole, David J ^a   Wilson Paul L Baron, Michael C ^b   O'Brien, Paul ^a   Reed, Carolyn ^a   Tsang, Kwong Y ^a   Schlom, Jeffrey ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PEPTIDE; RECOMBINANT VACCINE; VIRUS VACCINE;

ADENOCARCINOMA; ADULT; AGED; ANIMAL; ARTICLE; BREAST TUMOR; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL TUMOR; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; LUNG TUMOR; MALE; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; VACCINATION; VACCINIA VIRUS;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL NEOPLASMS; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDES; VACCINATION; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES;

EID: 0030578211     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.11-1381     Document Type: Article

References (42)

1. BEBCHIMOL, S., FUKS, A., JOTHY, S. AND ET. AL. (1989) Carcinoembryonic antigen, a human tumor marker, functions as an intracellular adhesion molecule. Cell 57:327-334.
2. BENNICK, J.R., YEWDELL, J.W., SMITH, G.L. AND ET. AL. ( 1984) Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific antigens. Nature 311:578-579.
3. BERNARDS, R., DESTREE, A., MCKENZffi, S. AND ET. AL. (1987) Effective tumor immunotherapy directed against an oncogene-encoded produce using a vaccinia virus vector. Proc. Natl. Acad. Sei. USA 84:6854-6858.
4. BORING, C.S., SQUIRES, T.S. AND TONG, T. (1992) Cancer Statistics. CA-Cancer Journal for Clinicians 42:19-38.
5. CHEEVER M, CHEN W, NELSON H ET AL (1990) T-cell immunity to the oncogene form of ras protein can be induced by immunization with synthetic peptides. Cellular Immunity and the Immunotherapy of Cancer. Wiley-Liss.
6. CDC (1984): Contact spread of vaccinia from a recently vaccinated marine-Lousiana. MMWR 33:37-38.
7. CDC (1985): Contact spread of vaccinia from a National Guard vaccinee-Wisconsin. MMWR 34:182-183.
8. COONEY, E.L., COLLIER, A.C., GREENBERG, P.D. AND ET. AL. (1991) Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 337:567-572.
9. DATA ON FILE, RIBI IMMUNOCHEM RESEARCH, INC. Hamilton MT.
10. FUCHS, C., KRAPF, F., KERN, P. AND ET. AL. (1988) CEAcontaining immune complexes in sera of patients with colorectal and breast cancer-analysis of comlexed immunoglobulin classes. Cancer Immunol. Immunother. 26:180-184.
11. ESTIN, C.D., STEVENSON, U.S., PLOWMAN, G.D. AND ET. AL. (1988) Recombinant vaccinia virus against human melanoma antigen for p97 for use in immunotherapy. Proc. Natl. Acad. Sei. USA 85:1052-1056.
12. GOLD, P. AND FREEDMAN, S.O. (1985) Specific carcinoembryonic antigens of the human digestive system. J. Exp. Med. 122:467-481.
13. HELLSTROM, K.E. AND HELLSTROM, I. (1991) Cellular immunity against tumor specific antigens. Advan. Cancer Res. 12:167-223.
14. HAREUVENI, M., GAUTIER, C., KIERNEY, M.P. AND ET. AL. (1990) Vaccination against tumor cells expressing breast cancer epithelial tumor antigen. Proc. Natl. Acad. Sei. USA 87:9498-9502.
15. HERSHEY, P., EDWARDS, A., COATES, A. AND ET. AL. (1987) Evidence that treatment with vaccinia melanoma cell lysates may improve survival of patients with stage II melanoma. Cancer Immunol. Immunother. 25:257-265.
16. HU, S.L., KOSOWSKI, S.G. AND DALRYMPLE, J.M. (1986) Expression of AIDS virus envelope gene for recombinant vaccinia virus. Nature 325:257-265.
17. HU, S.L., PLOWMAN, G.D., SRIDHAR, P. AND ET. AL. (1988) Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen. J. Viral. 62:176-180.
18. KANTOR, J., IRVDME, K., ABRAMS, S., ET AL (1992) Anti-tumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J. Natl. Cancer Inst. 84:1084-1091.
19. KANTOR, J., IRVINE, K., ABRAMS, S., ET AL (1992) Immunogenicity and safety of a recombinant vaccinia virus vac-cine expressing the carcinoembryonic antigen gene in a nonhuman primate. Cancer Res. 52:6917-6925.
20. KAUFMAN, H., SCHOLM, J. AND KANTOR A. (1991) A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA). Int. J. Cancer 48:900-907.
21. KAWA, A. AND ARAKAWA, S. (1987) The effect of attenuated vaccinia virus strain on multiple myeloma: a case report. Jpn. J. Exp. Med. 57:79-81.
22. KIERNY, M.P., LATHE, R., DRILLEN, R. AND ET. AL. (1984) Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312:163-166.
23. LANGFORD, C.J. (1986) Live viruses for the delivery of malaria vaccines. Papua New Guinea Med. J. 29:103-108.
24. LATHE, R., KIERNY, M.P., GERLINGER, P. AND ET. AL. (1989) Tumor prevention and rejection with recombinant vaccinia. Nature 326:878-880, 1987.
25. MACKETT, M. (1987) Vaccinia virus recombinants: potential vaccines. ACTA Trop 445:94-97.
26. MOSS, B. (1991) Vaccinia virus: a tool for research and vaccine development. Science 252:1662-1667.
27. MOSS, B. AND FLEXNER, C. (1987) Vaccinia virus expression vectors. Ann. Rev. Immunol. 5:305-324.
28. MUTRARO, R., WUNDERLICH, D. AND THOR, D. (1985) Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res. 45;5769-5780.
29. NEFF, J.M. (1990) DNA viruses: Poxviridae. In: Principles and Practice of Infectious Diseases, edited by Mandell, G.L., Douglass, R.G., Jr. and Bennett, J.E. New York: Churchill Livingston, Inc. p. 1134-1139.
30. OIKAWA, S., NAKAZATO, M. and KOSAKI, G. (1987) Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem. Biophys. Res. Commun. 142:511-518.
31. PEACE DJ, CHGEN W, NELSON, CHEEVER MA. (1991) T-cell recognition of transforming proteins encoded by mutated ras protooncogenes. J. Immunol. 146:2059-2065.
32. PIGNATELLI, M., DURBIN, H. AND BOOMER, W.F. (1990) Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions. Proc. Natl. Acad. Sei. USA 87:1541-1545.
33. RIBI, E. (1984) Beneficial modification of endotoxin molecule. Journal of Biological Response Modifiers 3:1-9.
34. ROBBINS, P.F., KANTOR, J.A., SALGALLER, M. AND ET. AL. ( 1991 ) Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res. 51:3657-3662.
35. ROGERS, G.T. (1983) Carcinoembryonic antigens and related glycoproteins: molecular aspects and specificities. Biochimica et Biophys. Acta 695:227-249.
36. SHIVELY, L.E. AND ET. AL. (1985) CEA-related antigens molecular biology and clinical significance. Crit. Rev. Oncol. Hematol. 2:355-399.
37. SMITH, G.L., MACKETT, M. AND MOSS, B. (1983) Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302:490-495.
38. STEWARD, A.M., NIXON, D., ZAMCHECK, N. AND ET. AL. (1974) Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer 33:1246-1252.
39. VINCENT, R.G. AND CHU, T.M. (1978) Carcinoembryonic antigen in patients with carcinoma of the lung. J. Thorac. Cardiovasc. Surg. 66:320-328.
40. VON KLEIST, S. AND BURTIN, P. (1979) Antigens cross-reacting with CEA. In: Immunodiagnosis of Cancer, edited by Herberman, R.B. and Mclntire, K.R. New York: Marcel Dekkar, Inc. p. 322-341.
41. VON KLEIST, S., CHAVENEL, G. AND BURTIN, P. (1972) Identification of an antigen from normal human tissue that cross- reacts with the carcinoembryonic antigen. Proc Natl Acad Sei USA 69:2492-2494.
42. ZIMMERMANN, W., WEBER, B. AND ET. AL. (1988) Chromosomal localization of the carcinoembryonic antigen gene family and differential expression in various tumors. Cancer Res. 48:2550-2555.